Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1-Deficient Thoracic Cancers.
J Clin Oncol. 2017 Jun 1;35(16):1778-1785. doi: 10.1200/JCO.2016.71.3230. Epub 2017 Apr 7.
J Clin Oncol. 2017.
PMID: 28388291
Free PMC article.
Clinical Trial.
A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.
Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu BW, Bomalaski JS, Crook T, O'Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW.
Hall PE, et al. Among authors: khadeir rs.
Clin Cancer Res. 2019 May 1;25(9):2708-2716. doi: 10.1158/1078-0432.CCR-18-3729. Epub 2019 Feb 22.
Clin Cancer Res. 2019.
PMID: 30796035
Clinical Trial.
Item in Clipboard
Optimizing arginine deprivation for hard-to-treat cancers.
Khadeir R, Szyszko T, Szlosarek PW.
Khadeir R, et al.
Oncotarget. 2017 Oct 27;8(57):96468-96469. doi: 10.18632/oncotarget.22099. eCollection 2017 Nov 14.
Oncotarget. 2017.
PMID: 29228540
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite